FDA PreCheck pilot aims to speed U.S. pharma plant construction and approvals for critical medicines with earlier feedback.
The findings show diligence from the FDA and a need for clinicians to discuss risks, benefits, and unknowns with patients before using drugs with accelerated approval.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results